Failure to launch: white paper explores the role of inappropriate use of IP in blocking access to generic and biosimilar medicines

Medicines shortages and national stockpiling requirements in… 15 April 2024 Today, generic medicines are an integral part of the healthcare…
Medicines Procurement Reform: Strenghtening Supply Security… 13 February 2024 This paper explores how the design of off-patent multisource, generic…
Access to medicines and security of supply should be central… 13 June 2023 Generic and biosimilar medicines significantly lower healthcare treatment costs and…
Smart reform of EU pharma and IP legislation key to boosting… 28 June 2022 Generic and biosimilar medicines lower healthcare treatment costs dramatically and…